Workflow
恩华药业(002262) - 2023 Q3 - 季度财报
002262NHWA(002262)2023-10-25 16:00

Financial Performance - Revenue for the third quarter reached 1.26 billion yuan, a year-on-year increase of 12.21%[3] - Net profit attributable to shareholders of the listed company was 340.94 million yuan, up 15.82% year-on-year[3] - Total revenue for the first three quarters of 2023 reached 3.66 billion RMB, a 17.2% increase compared to the same period last year (3.12 billion RMB)[15] - Net profit attributable to the parent company's shareholders was 885.64 million RMB, up 19.4% year-over-year (741.87 million RMB)[16] - Operating profit grew by 18.5% to 1.01 billion RMB, up from 848.89 million RMB in the same period last year[16] - Comprehensive income for the period reached 883,414,665.34 yuan, with net income attributable to parent company owners at 885,641,307.43 yuan[17] - Basic and diluted earnings per share were both 0.88 yuan[17] Assets and Liabilities - Total assets as of the end of the reporting period were 7.14 billion yuan, an increase of 10.14% compared to the end of the previous year[3] - Total assets as of the end of Q3 2023 stood at 7.14 billion RMB, a 10.1% increase from 6.48 billion RMB at the beginning of the year[13][14] - The company's total liabilities decreased by 2.7% to 872.51 million RMB from 896.99 million RMB at the beginning of the year[14] - The company's equity attributable to the parent company's shareholders increased by 12.2% to 6.31 billion RMB from 5.62 billion RMB at the beginning of the year[14] - Fixed assets decreased by 2.0% to 1.12 billion RMB from 1.15 billion RMB at the beginning of the year[13] - Inventory decreased by 4.9% to 681.07 million RMB from 716.34 million RMB at the beginning of the year[13] Cash Flow - Cash flow from operating activities for the period was 818.65 million yuan, up 27.86% year-on-year[3] - Net increase in cash and cash equivalents rose by 156.10%, driven by cash flows from operating, investing, and financing activities[7] - Cash received from sales of goods and services amounted to 3,982,267,544.75 yuan, a significant increase from the previous period's 3,394,458,697.13 yuan[18] - Net cash flow from operating activities was 818,648,779.67 yuan, up from 640,255,311.63 yuan in the previous period[19] - Cash paid for employee benefits and taxes increased to 728,987,546.19 yuan and 502,942,259.77 yuan respectively[19] - Net cash flow from investing activities showed a negative figure of -67,828,518.11 yuan, an improvement from -202,186,041.45 yuan in the previous period[19] - Cash and cash equivalents at the end of the period stood at 2,026,653,961.98 yuan, compared to 1,776,932,975.89 yuan in the previous period[19] R&D and Intangible Assets - R&D expenses increased by 32.11% year-on-year, driven by increased R&D investment[6] - Intangible assets increased by 75.36% compared to the beginning of the period, due to the capitalization of R&D projects[6] - R&D expenses increased by 32.1% to 384.71 million RMB, compared to 291.21 million RMB in the same period last year[16] Financial Expenses and Credit Impairment - Financial expenses decreased by 72.43% year-on-year, mainly due to increased interest income[7] - Credit impairment losses increased by 110.07% year-on-year, mainly due to bad debt provisions for receivables[7] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 18,494[8] - The largest shareholder, Xuzhou Enhua Investment Co., Ltd., holds 320,096,321 shares, representing 31.77% of the total shares[8] - Sun Pengsheng, a domestic natural person, holds 39,928,590 shares, accounting for 4.91% of the total shares[8] Future Projections - The company expects a net profit attributable to shareholders of the listed company to increase by 10.00% to 30.00% in 2023, with a projected range of 991.02 million to 1,171.20 million yuan[11] Monetary Funds and Financial Assets - The company's monetary funds as of September 30, 2023, amounted to 2,066,306,976.55 yuan, an increase from 1,532,214,418.85 yuan at the beginning of the year[12] - The company's trading financial assets as of September 30, 2023, were 1,327,300,000.00 yuan, a decrease from 1,452,000,000.00 yuan at the beginning of the year[12] Receivables and Prepayments - The company's accounts receivable as of September 30, 2023, were 934,067,437.87 yuan, up from 820,838,563.92 yuan at the beginning of the year[12] - The company's other receivables as of September 30, 2023, were 79,767,106.28 yuan, a significant increase from 29,934,247.59 yuan at the beginning of the year[12] - The company's prepayments as of September 30, 2023, were 54,753,223.20 yuan, down from 63,397,454.72 yuan at the beginning of the year[12] - The company's receivables financing as of September 30, 2023, were 11,870,521.38 yuan, a decrease from 23,090,497.57 yuan at the beginning of the year[12] - Accounts receivable increased by 32.1% to 1.10 billion RMB, compared to 1.08 billion RMB in the same period last year[16] Audit Information - The company's third quarter report was not audited[20]